Literature DB >> 30566676

Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content.

Kristina M Utzschneider1,2, Steven E Kahn1,2, David C Polidori3.   

Abstract

CONTEXT: Total insulin clearance is decreased in nonalcoholic fatty liver disease (NAFLD), but the relationship between liver fat and hepatic insulin extraction (HIE) is unknown.
OBJECTIVE: This cross-sectional study addresses the hypothesis that HIE is reduced in NAFLD and investigates metabolic and/or anthropometric characteristics most closely associated with insulin clearance. PARTICIPANTS: Nondiabetic subjects with NAFLD (n = 13) and age- and body mass index (BMI)-matched controls with normal liver enzymes (n = 15) underwent abdominal CT, dual-energy X-ray absorptiometry, oral glucose tolerance test (OGTT), and labeled two-step hyperinsulinemic-euglycemic clamps. OUTCOME MEASUREMENTS: Liver fat was estimated by the CT liver/spleen ratio. Hepatic and extrahepatic insulin clearances were modeled using clamp and OGTT data.
RESULTS: Extrahepatic insulin clearance and HIE were not different between NAFLD and controls and did not correlate with liver fat. HIE was positively correlated with insulin sensitivity [rate of glucose disposal (Rd; low r = +0.7, P < 0.001; high r = +0.6, P = 0.001), adiponectin (r = +0.55, P = 0.004), and insulin-mediated suppression of clamp nonesterified free fatty acid (NEFA; r = +0.67, P < 0.001)] but was not associated with fasting NEFA, insulin-mediated suppression of glucose production, or measures of adiposity. Extrahepatic insulin clearance was positively associated with percent body fat (r = +0.44, P = 0.02) and subcutaneous fat (r = +0.42, P = 0.03) but not BMI, intra-abdominal fat, liver fat, Rd, adiponectin, or NEFA.
CONCLUSIONS: HIE is not directly associated with hepatic steatosis but is associated with muscle and adipose tissue insulin resistance. The data suggest differential regulation of insulin clearance with extrahepatic insulin clearance being associated with body fat and not insulin sensitivity. Published by Oxford University Press on behalf of the Endocrine Society 2019.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30566676      PMCID: PMC6456889          DOI: 10.1210/jc.2018-01808

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Intrahepatic fat, irrespective of ethnicity, is associated with reduced endogenous insulin clearance and hepatic insulin resistance in obese youths: A cross-sectional and longitudinal study from the Yale Pediatric NAFLD cohort.

Authors:  Domenico Tricò; Alfonso Galderisi; Andrea Mari; David Polidori; Brittany Galuppo; Bridget Pierpont; Stephanie Samuels; Nicola Santoro; Sonia Caprio
Journal:  Diabetes Obes Metab       Date:  2020-05-31       Impact factor: 6.577

2.  Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study.

Authors:  Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi
Journal:  Eur Respir J       Date:  2020-04-09       Impact factor: 16.671

Review 3.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

4.  Reduced Insulin Clearance and Insulin-Degrading Enzyme Activity Contribute to Hyperinsulinemia in African Americans.

Authors:  Andin Fosam; Shanaz Sikder; Brent S Abel; Sri Harsha Tella; Mary F Walter; Andrea Mari; Ranganath Muniyappa
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  Lower Insulin Clearance Parallels a Reduced Insulin Sensitivity in Obese Youths and Is Associated With a Decline in β-Cell Function Over Time.

Authors:  Alfonso Galderisi; David Polidori; Ram Weiss; Cosimo Giannini; Bridget Pierpont; Domenico Tricò; Sonia Caprio
Journal:  Diabetes       Date:  2019-08-09       Impact factor: 9.461

Review 6.  The Measurement of Insulin Clearance.

Authors:  Francesca Piccinini; Richard N Bergman
Journal:  Diabetes Care       Date:  2020-09       Impact factor: 19.112

7.  A Reduced Incretin Effect Mediated by the rs7903146 Variant in the TCF7L2 Gene Is an Early Marker of β-Cell Dysfunction in Obese Youth.

Authors:  Alfonso Galderisi; Domenico Tricò; Bridget Pierpont; Veronika Shabanova; Stephanie Samuels; Chiara Dalla Man; Brittany Galuppo; Nicola Santoro; Sonia Caprio
Journal:  Diabetes Care       Date:  2020-08-11       Impact factor: 19.112

Review 8.  The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.

Authors:  Giovanni Targher; Kathleen E Corey; Christopher D Byrne; Michael Roden
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-10       Impact factor: 46.802

9.  Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.

Authors:  Gordon I Smith; David C Polidori; Mihoko Yoshino; Monica L Kearney; Bruce W Patterson; Bettina Mittendorfer; Samuel Klein
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

10.  Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance.

Authors:  Amalia Gastaldelli; Muhammad Abdul Ghani; Ralph A DeFronzo
Journal:  Diabetes       Date:  2020-10-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.